89 related articles for article (PubMed ID: 196405)
1. [Nature of the proteinase activated by the contact factor in human blood plasma].
Veremeenko KN; Kizim AI; Lositskaia VM
Vopr Med Khim; 1977; (3):391-6. PubMed ID: 196405
[TBL] [Abstract][Full Text] [Related]
2. Study of TAMe (p-tosyl-L-arginine methyl ester) esterase activity of bovine plasma.
Claxton J; Black WD; Gentry PA
Am J Vet Res; 1978 Jul; 39(7):1235-8. PubMed ID: 677544
[TBL] [Abstract][Full Text] [Related]
3. Contact activation of human plasma prorenin in vitro.
Blumberg AL; Sealey JE; Atlas SA; Laragh JH; Dharmgrongartama B; Kaplan AP
J Lab Clin Med; 1981 Jun; 97(6):771-8. PubMed ID: 7014741
[TBL] [Abstract][Full Text] [Related]
4. [Chromatographic separation of activated proteases from human plasma].
Lehmann B; Taucher M; Kühne H; Scheuch DW
Biomed Biochim Acta; 1988; 47(4-5):363-71. PubMed ID: 2467663
[TBL] [Abstract][Full Text] [Related]
5. The role of prekallikrein and high-molecular-weight kininogen in the contact activation of Hageman factor (factor XII) by sulfatides and other agents.
España F; Ratnoff OD
J Lab Clin Med; 1983 Oct; 102(4):487-99. PubMed ID: 6604770
[TBL] [Abstract][Full Text] [Related]
6. Normal plasma arginine esterase and the Hageman factor (factor XII) -prekallikrein-kininogen system in cystic fibrosis.
Goldsmith GH; Stern RC; Saito H; Ratnoff OD
J Lab Clin Med; 1977 Jan; 89(1):131-4. PubMed ID: 830773
[TBL] [Abstract][Full Text] [Related]
7. Plasma kallikrein during experimentally induced allergic rhinitis: role in kinin formation and contribution to TAME-esterase activity in nasal secretions.
Baumgarten CR; Nichols RC; Naclerio RM; Lichtenstein LM; Norman PS; Proud D
J Immunol; 1986 Aug; 137(3):977-82. PubMed ID: 3522740
[TBL] [Abstract][Full Text] [Related]
8. Plasma arginine esterase in cystic fibrosis: kinetics of activation, identification as plasma kallikrein, reaction with alpha 2-macroglobulin and comparison with levels in normal plasma.
Bury AF; Barrett AJ
Pediatr Res; 1982 Aug; 16(8):613-20. PubMed ID: 6180371
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of aprotinin and gabexate mesilate on human plasma kallikrein.
Nakahara M
Arzneimittelforschung; 1983; 33(7):969-71. PubMed ID: 6194800
[TBL] [Abstract][Full Text] [Related]
10. Studies on the prekallikrein (kallikreinogen)--kallikrein enzyme system of human plasma. II. Evidence relating the kaolin-activated arginine esterase to plasma kallikrein.
Colman RW; Mattler L; Sherry S
J Clin Invest; 1969 Jan; 48(1):23-32. PubMed ID: 4237065
[TBL] [Abstract][Full Text] [Related]
11. Dose dependence of endotoxin-induced activation of the plasma contact system: an in vitro study.
Roeise O; Bouma BN; Stadaas JO; Aasen AO
Circ Shock; 1988 Dec; 26(4):419-30. PubMed ID: 2463883
[TBL] [Abstract][Full Text] [Related]
12. [Effect of precipitating antibodies to pancreatic kallikrein on arginine esterase contact activation in human and rabbit blood].
Karpitskiĭ VV; Guz SIa
Vopr Med Khim; 1979; 25(3):242-5. PubMed ID: 452486
[TBL] [Abstract][Full Text] [Related]
13. [Method of simultaneous determination of kallikrein, plasmin and thrombin precursors and inhibitors in human blood plasma].
Gomazkov OA; Komissarova NV
Biull Eksp Biol Med; 1976 May; 81(5):632-4. PubMed ID: 132976
[TBL] [Abstract][Full Text] [Related]
14. [Effect of proteolysis inhibitors on serum proteinase activity and its antitryptic activity in postischemic toxemia].
Protsenko VA; Kharchenko VZ; Veselov VF; Spitsyn IF; Bogadel'nikov IV
Farmakol Toksikol; 1978; 41(6):693-6. PubMed ID: 720581
[TBL] [Abstract][Full Text] [Related]
15. Factor XII fragment and kallikrein generation in plasma during incubation with biomaterials.
van der Kamp KW; van Oeveren W
J Biomed Mater Res; 1994 Mar; 28(3):349-52. PubMed ID: 7521336
[TBL] [Abstract][Full Text] [Related]
16. Contact-activated fibrinolysis: role of surface concentration and high-molecular-weight kininogen.
Goldsmith GH
J Lab Clin Med; 1980 Aug; 96(2):222-31. PubMed ID: 7400661
[TBL] [Abstract][Full Text] [Related]
17. Alteration of factor VII activity by activated Fletcher factor (a plasma kallikrein): a potential link between the intrinsic and extrinsic blood-clotting systems.
Saito H; Ratnoff OD
J Lab Clin Med; 1975 Mar; 85(3):405-15. PubMed ID: 234996
[TBL] [Abstract][Full Text] [Related]
18. Activation of human factor VII in plasma and in purified systems: roles of activated factor IX, kallikrein, and activated factor XII.
Seligsohn U; Osterud B; Brown SF; Griffin JH; Rapaport SI
J Clin Invest; 1979 Oct; 64(4):1056-65. PubMed ID: 479368
[TBL] [Abstract][Full Text] [Related]
19. [Characteristics of contact activation of rabbit blood (kallikrein and plasmin systems].
Komissarova NV; Gomazkov OA
Biull Eksp Biol Med; 1976; 81(4):390-2. PubMed ID: 132208
[TBL] [Abstract][Full Text] [Related]
20. Development of plasma kallikrein selective inhibitors.
Okada Y; Tsuda Y; Tada M; Wanaka K; Hijikata-Okunomiya A; Okamoto U; Okamoto S
Biopolymers; 1999; 51(1):41-50. PubMed ID: 10380351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
